Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Anolik

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Arthritis & Rheumatology (Hoboken, N.J.)|June 10, 2014
Primary Sjögren's syndrome is characterized by distinct phenotypic and transcriptional profiles of IgD+ unswitched memory B cellsMustimbo E P Roberts, Denise Kaminski, Scott A Jenks, et al.
Annals of the Rheumatic Diseases|March 7, 2020
Disruptive innovation in rheumatology: new networks of global public-private partnerships are needed to take advantage of scientific progressTom Wj Huizinga, V Michael Holers, Jennifer Anolik, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 4, 2023
Associations Between Rheumatoid Arthritis Clinical Factors and Synovial Cell Types and StatesDana Weisenfeld, Fan Zhang, Laura Donlin, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Serum proteomic atlas reveals distinct molecular signatures of lupus nephritis activity, chronicity, and treatment responseRufei Lu, Catriona A Wagner, Andrea Fava, et al.
Rheumatology (Oxford, England)|March 26, 2024
Extrarenal symptoms associate with worse quality of life in patients enrolled in the AMP RA/SLE Lupus Nephritis NetworkPhilip M Carlucci, Katherine Preisinger, Kristina K Deonaraine, et al.
Arthritis Care & Research|October 6, 2025
Serum Soluble Mediator Signatures of Lupus Nephritis: Histologic Features and Response to TreatmentAndrea Fava, Catriona A Wagner, Carla J Guthridge, et al.
Arthritis Research & Therapy|February 20, 2024
Longitudinal patterns and predictors of response to standard-of-care therapy in lupus nephritis: data from the Accelerating Medicines Partnership Lupus NetworkPeter M Izmirly, Mimi Y Kim, Philip M Carlucci, et al.
Lupus Science & Medicine|August 14, 2021
Safety of procuring research tissue during a clinically indicated kidney biopsy from patients with lupus: data from the Accelerating Medicines Partnership RA/SLE NetworkKristina K Deonaraine, Philip M Carlucci, Andrea Fava, et al.
Rheumatology (Oxford, England)|February 25, 2022
High incidence of proliferative and membranous nephritis in SLE patients with low proteinuria in the Accelerating Medicines PartnershipPhilip M Carlucci, Jessica Li, Andrea Fava, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Arthritis & Rheumatology (Hoboken, N.J.)|June 10, 2014
Primary Sjögren's syndrome is characterized by distinct phenotypic and transcriptional profiles of IgD+ unswitched memory B cellsMustimbo E P Roberts, Denise Kaminski, Scott A Jenks, et al.
Annals of the Rheumatic Diseases|March 7, 2020
Disruptive innovation in rheumatology: new networks of global public-private partnerships are needed to take advantage of scientific progressTom Wj Huizinga, V Michael Holers, Jennifer Anolik, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 4, 2023
Associations Between Rheumatoid Arthritis Clinical Factors and Synovial Cell Types and StatesDana Weisenfeld, Fan Zhang, Laura Donlin, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Serum proteomic atlas reveals distinct molecular signatures of lupus nephritis activity, chronicity, and treatment responseRufei Lu, Catriona A Wagner, Andrea Fava, et al.
Rheumatology (Oxford, England)|March 26, 2024
Extrarenal symptoms associate with worse quality of life in patients enrolled in the AMP RA/SLE Lupus Nephritis NetworkPhilip M Carlucci, Katherine Preisinger, Kristina K Deonaraine, et al.
Arthritis Care & Research|October 6, 2025
Serum Soluble Mediator Signatures of Lupus Nephritis: Histologic Features and Response to TreatmentAndrea Fava, Catriona A Wagner, Carla J Guthridge, et al.
Arthritis Research & Therapy|February 20, 2024
Longitudinal patterns and predictors of response to standard-of-care therapy in lupus nephritis: data from the Accelerating Medicines Partnership Lupus NetworkPeter M Izmirly, Mimi Y Kim, Philip M Carlucci, et al.
Lupus Science & Medicine|August 14, 2021
Safety of procuring research tissue during a clinically indicated kidney biopsy from patients with lupus: data from the Accelerating Medicines Partnership RA/SLE NetworkKristina K Deonaraine, Philip M Carlucci, Andrea Fava, et al.
Rheumatology (Oxford, England)|February 25, 2022
High incidence of proliferative and membranous nephritis in SLE patients with low proteinuria in the Accelerating Medicines PartnershipPhilip M Carlucci, Jessica Li, Andrea Fava, et al.
Pageof 3